98 related articles for article (PubMed ID: 29685196)
1. IL-2/IL-3 interplay mediates growth of CD25 positive acute myeloid leukemia cells.
Nakase K; Kita K; Katayama N
Med Hypotheses; 2018 Jun; 115():5-7. PubMed ID: 29685196
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Relevance of Cytokine Receptor Expression in Acute Myeloid Leukemia: Interleukin-2 Receptor α-Chain (CD25) Expression Predicts a Poor Prognosis.
Nakase K; Kita K; Kyo T; Ueda T; Tanaka I; Katayama N
PLoS One; 2015; 10(9):e0128998. PubMed ID: 26375984
[TBL] [Abstract][Full Text] [Related]
3. Elevated frequencies of CD4⁺ CD25⁺ CD127lo regulatory T cells is associated to poor prognosis in patients with acute myeloid leukemia.
Shenghui Z; Yixiang H; Jianbo W; Kang Y; Laixi B; Yan Z; Xi X
Int J Cancer; 2011 Sep; 129(6):1373-81. PubMed ID: 21105040
[TBL] [Abstract][Full Text] [Related]
4. Increased population of CD4(+)CD25(high), regulatory T cells with their higher apoptotic and proliferating status in peripheral blood of acute myeloid leukemia patients.
Wang X; Zheng J; Liu J; Yao J; He Y; Li X; Yu J; Yang J; Liu Z; Huang S
Eur J Haematol; 2005 Dec; 75(6):468-76. PubMed ID: 16313258
[TBL] [Abstract][Full Text] [Related]
5. IL-2/CD25 axis mediates cellular networks promoting the growth of CD25
Nakase K; Kita K
Leuk Res Rep; 2024; 21():100454. PubMed ID: 38516380
[TBL] [Abstract][Full Text] [Related]
6. Elevated expression of IL-3Ralpha in acute myelogenous leukemia is associated with enhanced blast proliferation, increased cellularity, and poor prognosis.
Testa U; Riccioni R; Militi S; Coccia E; Stellacci E; Samoggia P; Latagliata R; Mariani G; Rossini A; Battistini A; Lo-Coco F; Peschle C
Blood; 2002 Oct; 100(8):2980-8. PubMed ID: 12351411
[TBL] [Abstract][Full Text] [Related]
7. IL-2/B7.1 (CD80) fusagene transduction of AML blasts by a self-inactivating lentiviral vector stimulates T cell responses in vitro: a strategy to generate whole cell vaccines for AML.
Chan L; Hardwick N; Darling D; Galea-Lauri J; Gäken J; Devereux S; Kemeny M; Mufti G; Farzaneh F
Mol Ther; 2005 Jan; 11(1):120-31. PubMed ID: 15585413
[TBL] [Abstract][Full Text] [Related]
8. A novel nonradioactive CFDA assay to monitor the cellular immune response in myeloid leukemia.
Yang T; Chen ZZ; Kolb HJ; Buhmann R
Immunobiology; 2013 Apr; 218(4):548-53. PubMed ID: 22883564
[TBL] [Abstract][Full Text] [Related]
9. Clinical value of CD25/CD123 co-expression in acute myeloid leukemia patients.
Aref S; Azmy E; El Ghannam D; Haroun M; Ibrahim L; Sabry M
Cancer Biomark; 2020; 29(1):9-16. PubMed ID: 32417762
[TBL] [Abstract][Full Text] [Related]
10. CD25 as an adverse prognostic factor in elderly patients with acute myeloid leukemia.
Fujiwara SI; Muroi K; Yamamoto C; Hatano K; Okazuka K; Sato K; Oh I; Ohmine K; Suzuki T; Ozawa K
Hematology; 2017 Jul; 22(6):347-353. PubMed ID: 28097942
[TBL] [Abstract][Full Text] [Related]
11. Time-Dependent Regulation of IL-2R α-Chain (CD25) Expression by TCR Signal Strength and IL-2-Induced STAT5 Signaling in Activated Human Blood T Lymphocytes.
Shatrova AN; Mityushova EV; Vassilieva IO; Aksenov ND; Zenin VV; Nikolsky NN; Marakhova II
PLoS One; 2016; 11(12):e0167215. PubMed ID: 27936140
[TBL] [Abstract][Full Text] [Related]
12. Regulatory T cells-derived IL-35 promotes the growth of adult acute myeloid leukemia blasts.
Tao Q; Pan Y; Wang Y; Wang H; Xiong S; Li Q; Wang J; Tao L; Wang Z; Wu F; Zhang R; Zhai Z
Int J Cancer; 2015 Nov; 137(10):2384-93. PubMed ID: 25866142
[TBL] [Abstract][Full Text] [Related]
13. [Expression of CD25 in Acute Myeloid Leukemia Is An Adverse Prognostic Factor Independent of the Chromosome Karyotype].
Liu YF; Dong L; Wang C; Sun H; Zhang QT; Wang M; Li T; Xu Y; Ma J; Xie XS; Sun L; Wan DM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):332-5. PubMed ID: 27150987
[TBL] [Abstract][Full Text] [Related]
14. Soluble interleukin-2 receptor α activation in a Children's Oncology Group randomized trial of interleukin-2 therapy for pediatric acute myeloid leukemia.
Lange BJ; Yang RK; Gan J; Hank JA; Sievers EL; Alonzo TA; Gerbing RB; Sondel PM
Pediatr Blood Cancer; 2011 Sep; 57(3):398-405. PubMed ID: 21681921
[TBL] [Abstract][Full Text] [Related]
15. [The surface expression of CD25 at different stages of proliferative response in human lymphocytes. II. The role of interleukin-2].
Shatrova AN; Zenin VV; Aksenov ND; Mitiushova EV; Marakhova II
Tsitologiia; 2011; 53(8):652-8. PubMed ID: 21961284
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-7 optimizes FOXP3+CD4+ regulatory T cells reactivity to interleukin-2 by modulating CD25 expression.
Simonetta F; Gestermann N; Bloquet S; Bourgeois C
PLoS One; 2014; 9(12):e113314. PubMed ID: 25485946
[TBL] [Abstract][Full Text] [Related]
17. Role of mitogen-activated protein kinases in Thy-1-induced T-lymphocyte activation.
Conrad DM; Furlong SJ; Doucette CD; Boudreau RT; Hoskin DW
Cell Signal; 2009 Aug; 21(8):1298-307. PubMed ID: 19324083
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-2 receptor alpha-chain (CD25) expression on leukaemic blasts is predictive for outcome and level of residual disease in AML.
Terwijn M; Feller N; van Rhenen A; Kelder A; Westra G; Zweegman S; Ossenkoppele G; Schuurhuis GJ
Eur J Cancer; 2009 Jun; 45(9):1692-9. PubMed ID: 19321337
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
[TBL] [Abstract][Full Text] [Related]
20. Expression of CD25 fluctuates in the leukemia-initiating cell population of CD25-positive AML.
Kageyama Y; Miwa H; Arakawa R; Tawara I; Ohishi K; Masuya M; Nakase K; Katayama N
PLoS One; 2018; 13(12):e0209295. PubMed ID: 30550585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]